Marker Therapeutics Inc (MRKR)

[Phantom Lord]

We already know what to be expecting by the end of the year. The company should be hearing from the FDA very soon regarding their pivotal PII trial. While it's not huge news it should help alleviate some concern. On their last conference call a moth ago they said we would be getting an update from the pancreatic trial next year. Per one of the conferences, if I remember correctly, they said the update should come by the end of this year now. So These are the only two expected news events that could be coming by the end of the year. The only other thing I will add is that it wouldn't surprise me to get news of a partnership at some point. I wouldn't expect it by the end of this year but next year is a possibility. I don't think that helps the technical picture right now but its something to keep an eye on in the first half of next year.